United States

Securities and Exchange Commission

Washington, D.C. 20549

 

 

Form SD

 

 

Specialized Disclosure Report

 

 

INTEGRA LIFESCIENCES HOLDINGS CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware		0-26224		51-0317849
(State or other jurisdiction of incorporation or organization)		Commission File Number		(I.R.S. Employer Identification No.)

311 ENTERPRISE DRIVE

PLAINSBORO, NEW JERSEY 08536

(Address of principal executive offices)

 

Glenn G. Coleman Corporate Vice President and Chief Financial Officer		(609) 275-0500

(Name and telephone number, including area code, of the person to contact in connection with this report)

 

 

The rule pursuant to which this form is being filed, and the period to which the information in this form applies:

 

x	Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2013.

 

 

 

---

Section 1—Conflict Minerals Disclosure

Item 1.01 and 1.02 Conflict Minerals Disclosure and Exhibit

Integra LifeSciences Holdings Corporation (“Integra,” the “Company”, “we”, “us” or “our”) is unable, at this time, to determine whether any of the tin, tantalum, tungsten or gold (the “Conflict Minerals”) used in its products may have originated in the Democratic Republic of the Congo or adjoining countries. Some of our suppliers have identified that products they provide to us may include recycled Conflict Minerals.

A Conflict Minerals Report is provided as an Exhibit to this Report under Section 2.01 below, and is available at the following internet website: http://www.integralife.com/index.aspx?redir=ConflictMinerals.

The Conflict Minerals Report is not required to be audited.

Section 2 – Exhibits

Item 2.01 – Exhibits

Exhibit 1.02 – Conflict Minerals Report

A Conflict Minerals Report is attached.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

INTEGRA LIFESCIENCES HOLDINGS CORPORATION

 

By:		/s/ Glenn G. Coleman						June 2, 2014
		Glenn G. Coleman
		Corporate Vice President
		and Chief Financial Officer

 

2